Cargando…
Reply: Unblinding in the lecanemab trial in Alzheimer’s disease
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629754/ https://www.ncbi.nlm.nih.gov/pubmed/37609937 http://dx.doi.org/10.1093/brain/awad201 |
| _version_ | 1785132023702093824 |
|---|---|
| author | Hardy, John Mummery, Catherine |
| author_facet | Hardy, John Mummery, Catherine |
| author_sort | Hardy, John |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10629754 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106297542023-11-08 Reply: Unblinding in the lecanemab trial in Alzheimer’s disease Hardy, John Mummery, Catherine Brain Letter to the Editor Oxford University Press 2023-05-23 /pmc/articles/PMC10629754/ /pubmed/37609937 http://dx.doi.org/10.1093/brain/awad201 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Letter to the Editor Hardy, John Mummery, Catherine Reply: Unblinding in the lecanemab trial in Alzheimer’s disease |
| title | Reply: Unblinding in the lecanemab trial in Alzheimer’s disease |
| title_full | Reply: Unblinding in the lecanemab trial in Alzheimer’s disease |
| title_fullStr | Reply: Unblinding in the lecanemab trial in Alzheimer’s disease |
| title_full_unstemmed | Reply: Unblinding in the lecanemab trial in Alzheimer’s disease |
| title_short | Reply: Unblinding in the lecanemab trial in Alzheimer’s disease |
| title_sort | reply: unblinding in the lecanemab trial in alzheimer’s disease |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629754/ https://www.ncbi.nlm.nih.gov/pubmed/37609937 http://dx.doi.org/10.1093/brain/awad201 |
| work_keys_str_mv | AT hardyjohn replyunblindinginthelecanemabtrialinalzheimersdisease AT mummerycatherine replyunblindinginthelecanemabtrialinalzheimersdisease |